Van Ness says that he hesitated on revealing his status to the wold because he didn't want his “whole career to be necessarily defined by it.”
What is happening?
The activists have called out the FDA for giving Gilead Sciences, who have been repeatedly accused of price gouging, a monopoly on a possible COVID-19 treatment.
The program could also cost uninsured people up to $1,000 per year.
It will be housed in an Oakland warehouse.
Experts say, however, there’s no reason to panic.
Advocates have discovered that the drugmaker never sought exclusivity for manufacturing Truvada.